PRODUCTION, PURIFICATION AND CHARACTERIZATION OF A RABBIT RECOMBINANT IL-1 RECEPTOR ANTAGONIST

被引:21
作者
MATSUKAWA, A [1 ]
MORI, S [1 ]
OHKAWARA, S [1 ]
MAEDA, T [1 ]
TANASE, S [1 ]
EDAMITSU, S [1 ]
YANAGI, F [1 ]
YOSHINAGA, M [1 ]
机构
[1] KUMAMOTO UNIV, SCH MED, DEPT BIOCHEM, KUMAMOTO 860, JAPAN
来源
BIOMEDICAL RESEARCH-TOKYO | 1992年 / 13卷 / 04期
关键词
D O I
10.2220/biomedres.13.269
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We describe here the mature translation product of the cDNA for rabbit IL-1 receptor antagonist (IL-1ra) expressed in E.coli. The rabbit recombinant IL-1ra (rrIL-1ra) was purified using DEAE-cellulose and Sephadex G-75, in a conventional chromatography system, followed by a linear NaCl gradient-elution of DEAE-cellulose in an FPLC system. The purified rrIL-1ra was composed of 143 amino acid residues. It had a molecular mass of 19 kD on SDS-PAGE and an isoelectric point of 5.85 on IEF-PAGE. Amino acid sequence analysis of rrIL-1ra showed that the native N-terminal Met was maintained. Specific biological activity of rrIL-1ra was 2.5 x 10(5) units/mg protein, a value indistinguishable from that of the native factor of rabbit inflammatory exudate cells when assessed by using thymocyte co-mitogenic assay. These observations suggest that rrIL-1ra emulates properties of the native protein. This rrIL-1ra manifested inhibition of rabbit rIL-1-beta- and human rIL-1-alpha- and rIL-1-beta-induced proliferation of mouse thymocytes and also inhibited IL-1 activities in culture supernatants of mononuclear cells from animals, including the rabbit, rat, mouse, guinea pig and from human. Thus, rrIL-1ra provides a useful tool for testing IL-1 activities exhibited by both IL-1-alpha and beta in a wide range of species of experimental animals.
引用
收藏
页码:269 / 277
页数:9
相关论文
共 25 条
[1]  
AREND WP, 1989, J IMMUNOL, V143, P1851
[2]   L-TRANS-EPOXYSUCCINYL-LEUCYLAMIDO(4-GUANIDINO)BUTANE (E-64) AND ITS ANALOGS AS INHIBITORS OF CYSTEINE PROTEINASES INCLUDING CATHEPSINS B, H AND L [J].
BARRETT, AJ ;
KEMBHAVI, AA ;
BROWN, MA ;
KIRSCHKE, H ;
KNIGHT, CG ;
TAMAI, M ;
HANADA, K .
BIOCHEMICAL JOURNAL, 1982, 201 (01) :189-198
[3]   PURIFICATION, CLONING, EXPRESSION AND BIOLOGICAL CHARACTERIZATION OF AN INTERLEUKIN-1 RECEPTOR ANTAGONIST PROTEIN [J].
CARTER, DB ;
DEIBEL, MR ;
DUNN, CJ ;
TOMICH, CSC ;
LABORDE, AL ;
SLIGHTOM, JL ;
BERGER, AE ;
BIENKOWSKI, MJ ;
SUN, FF ;
MCEWAN, RN ;
HARRIS, PKW ;
YEM, AW ;
WASZAK, GA ;
CHOSAY, JG ;
SIEU, LC ;
HARDEE, MM ;
ZURCHERNEELY, HA ;
REARDON, IM ;
HEINRIKSON, RL ;
TRUESDELL, SE ;
SHELLY, JA ;
EESSALU, TE ;
TAYLOR, BM ;
TRACEY, DE .
NATURE, 1990, 344 (6267) :633-638
[4]   INTERLEUKIN-1 (IL-1) GENE-EXPRESSION, SYNTHESIS, AND EFFECT OF SPECIFIC IL-1 RECEPTOR BLOCKADE IN RABBIT IMMUNE-COMPLEX COLITIS [J].
COMINELLI, F ;
NAST, CC ;
CLARK, BD ;
SCHINDLER, R ;
LLERENA, R ;
EYSSELEIN, VE ;
THOMPSON, RC ;
DINARELLO, CA .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (03) :972-980
[5]  
DIGIOVINE FS, 1990, IMMUNOL TODAY, V11, P13
[6]   BLOCKING IL-1 - INTERLEUKIN-1 RECEPTOR ANTAGONIST INVIVO AND INVITRO [J].
DINARELLO, CA ;
THOMPSON, RC .
IMMUNOLOGY TODAY, 1991, 12 (11) :404-410
[7]  
DINARELLO CA, 1989, ADV IMMUNOL, V44, P153, DOI [10.1016/s0065-2776(08)60642-2, 10.1016/S0065-2776(08)60642-2, DOI 10.1016/S0065-2776(08)60642-2]
[8]   PRIMARY STRUCTURE AND FUNCTIONAL EXPRESSION FROM COMPLEMENTARY-DNA OF A HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST [J].
EISENBERG, SP ;
EVANS, RJ ;
AREND, WP ;
VERDERBER, E ;
BREWER, MT ;
HANNUM, CH ;
THOMPSON, RC .
NATURE, 1990, 343 (6256) :341-346
[9]  
GOTO F, 1989, BRIT J EXP PATHOL, V70, P597
[10]  
GOTO F, 1992, IN PRESS IMMUNOLOGY, V76